These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26531067)

  • 1. The use of ovarian reserve markers in IVF clinical practice: a national consensus.
    La Marca A; Ferraretti AP; Palermo R; Ubaldi FM
    Gynecol Endocrinol; 2016; 32(1):1-5. PubMed ID: 26531067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
    Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
    Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
    Chan C; Liu K
    J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.
    Papaleo E; Zaffagnini S; Munaretto M; Vanni VS; Rebonato G; Grisendi V; Di Paola R; La Marca A
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():94-99. PubMed ID: 27835829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1056-63. PubMed ID: 26184379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
    He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
    La Marca A; Sunkara SK
    Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of antral follicle count and anti-Müllerian hormone for follicle and oocyte developmental competence during the early prepubertal period in a sheep model.
    Torres-Rovira L; Gonzalez-Bulnes A; Succu S; Spezzigu A; Manca ME; Leoni GG; Sanna M; Pirino S; Gallus M; Naitana S; Berlinguer F
    Reprod Fertil Dev; 2014 Oct; 26(8):1094-106. PubMed ID: 24008140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
    La Marca A; Papaleo E; Grisendi V; Argento C; Giulini S; Volpe A
    BJOG; 2012 Sep; 119(10):1171-9. PubMed ID: 22805536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis.
    Peluso C; Oliveira R; Laporta GZ; Christofolini DM; Fonseca FLA; Laganà AS; Barbosa CP; Bianco B
    Gynecol Endocrinol; 2021 Apr; 37(4):358-366. PubMed ID: 32613875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.
    La Marca A; D'Ippolito G
    Reprod Biomed Online; 2014 Feb; 28(2):183-90. PubMed ID: 24368127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization.
    Feferkorn I; Ata B; Esteves SC; La Marca A; Paulson R; Blockeel C; Conforti A; Fatemi HM; Humaidan P; Lainas GT; Mol BW; Norman RJ; Orvieto R; Polyzos NP; Santos-Ribeiro S; Sunkara SK; Tan SL; Ubaldi FM; Urman B; Velasco JG; Weissman A; Yarali H; Dahan MH
    J Assist Reprod Genet; 2023 May; 40(5):1071-1081. PubMed ID: 36933094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.